Annual jab for HIV protection passes trial hurdle
An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...
MIT Technology Review13d
This annual shot might protect against HIV infections
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
“Magic” for Those Who Can’t Take Pills: Groundbreaking HIV Treatment Achieves 98% Viral Suppression
UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...
HIV Protection in One Injection? Gilead’s Lenacapavir Could Be a Game-Changer!
A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term ...
Science Daily12d
Injectable Therapy is 'magic' for those who can't take HIV pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
There are daily pills to prevent HIV — but injectable options could change what prevention looks like
Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...
Gilead plots trial of groundbreaking, once-a-year HIV prevention drug lenacapavir
Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.
LGBTQ Nation14d
Once-a-year shot for HIV protection passes early safety trial
PrEP delivered with a daily pill or bi-monthly injections ... The lenacapavir trial consisted of 40 people without HIV receiving a muscle-directed shot of the drug. No major side effects or ...
UC San Francisco21d
Injectable Therapy Is ‘Magic’ for Those Who Can’t Take HIV Pills
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study by researchers at UC San Francisco has found. The strategy could also help stop the spread ...